Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up. Dahan, Karine; Debiec, Hanna; Plaisier, Emmanuelle; Cachanado, Marine; Rousseau, Alexandra; Wakselman, Laura; Michel, Pierre-Antoine; Mihout, Fabrice; Dussol, Bertrand; Matignon, Marie; Mousson, Christiane; Simon, Tabassome; Ronco, Pierre; GEMRITUX Study Group. Journal of the American Society of Nephrology: JASN. 2017; 28: p.348-358. doi:10.1681/ASN.2016040449Article
Épidémiologie clinique